163796
Adapting the Fetal and Infant Mortality Review (Fimr) Process to Address Mch-Related Morbidity Events
Ann Koontz, DrPH, CNM
,
Maternal and Child Health Bureau (retired), Health Resources and Services Administration, Columbia, MD
Madelyn Renteria, RN, MPA
,
Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD
This poster summarizes the experience gained to date about use of the FIMR process to examine a broader range of sentinel events affecting the maternal and child health population (MCH) that result in morbidity but not necessarily mortality. The FIMR process is an effective public health intervention originally designed to address local systems issues associated with fetal and infant mortality. In this process, information is gathered about individual cases, including medical information and a maternal interview. Review of anonymous cases serves as a spring board for local community action to improve service systems and resources for women, infants and families. On occasion, local MCH data may indicate a need for deliberate community examination of another type of sentinel event. The FIMR process has been customized to accommodate review of such cases. Initial adaptations concentrated on other mortality reviews. Recent attention has focused on morbidity reviews. Sentinel events of interest include: prenatal domestic violence, preterm/low birth weight births, infant birth defects (e.g., suspected fetal alcohol syndrome disorders), and infant infectious diseases (e.g., perinatal HIV, syphilis).
Learning Objectives: At the end of this poster, participants will be able to:
• Describe the FIMR process and its essential characteristics to be applied in an MCH morbidity review process
• Discuss three adaptations of the FIMR process for reviewing morbidity sentinel events
• Understand issues that may emerge and strategies for adapting the FIMR process to address MCH morbidity events
Keywords: Infant Mortality, Infant Health
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|